Research review
Does zinc help with inflammation? What the research does and doesn't show
Two meta-analyses of randomized trials found blood markers of inflammation, particularly C-reactive protein (CRP), were lower in adults taking zinc than in those who weren't. The effect was largest at doses around 50 mg/day and in people with kidney dysfunction, and heterogeneity across the pooled trials was high.
The evidence doesn't support zinc as a treatment for any specific inflammatory condition, but two meta-analyses of randomized trials found blood markers of inflammation, especially C-reactive protein (CRP), were lower in adults taking zinc than in those who weren't. The benefit was strongest at doses around 50 mg/day and in people with kidney dysfunction, and neither analysis tested whether the lower marker levels changed how anyone actually felt.
What the evidence doesn't support
It doesn't support zinc as a treatment for arthritis, autoimmune disease, chronic pain, or any other specific inflammatory condition — neither meta-analysis below tested a named disease as its outcome. It also doesn't establish that lowering a blood marker like CRP with zinc translates into fewer symptoms or a lower disease risk; both analyses measured the marker itself, not a clinical outcome.
What the trials found
A 2021 meta-analysis pooled 8 randomized controlled trials of zinc supplementation and plasma CRP in adults. Across the pooled trials, CRP was on average about 1.68 mg/L lower with zinc than without (95% CI -2.4 to -0.9, p<0.001). Subgroup analysis found the CRP difference was larger at doses of 50 mg/day or more, and larger still in people with kidney dysfunction (about 7.4 mg/L lower) compared with otherwise-healthy subjects. It also found lower-quality studies reported bigger effects than higher-quality ones — a pattern that tends to inflate a pooled result, and a limitation worth taking at face value rather than glossing over.
A second, separate 2021 meta-analysis pooled 21 randomized controlled trials (1,321 adults) and looked at a wider set of markers. CRP, TNF-alpha (a signaling protein involved in the inflammatory response) and malondialdehyde (a marker of oxidative stress) were each significantly lower, on average, in the zinc groups. Heterogeneity across the 21 trials was very high for CRP and malondialdehyde (I² above 75%), meaning the individual trials disagreed with each other substantially about the size of the effect — a real limitation on how much confidence to put in the pooled number.
Both analyses pooled trials across a mix of populations and health conditions rather than restricting to healthy adults on a typical supplement dose, so what a healthy person taking a standard amount of zinc should expect from these markers isn't established by either one.
| Marker | 2021 analysis (8 trials) | 2021 analysis (21 trials) |
|---|---|---|
| CRP | -1.68 mg/L overall; -1.97 at ≥50 mg/day; -7.43 in kidney dysfunction | -0.92 mg/L; very high heterogeneity (I2=90%) |
| TNF-alpha | Not reported | -0.49 pg/mL; moderate heterogeneity |
| Oxidative stress marker | Not reported | Malondialdehyde -0.42; very high heterogeneity |
Questions people ask
Do zinc supplements help with inflammation?
Two meta-analyses found blood markers linked to inflammation, particularly CRP, were lower on average in adults taking zinc, with a bigger difference at higher doses (around 50 mg/day) and in people with kidney dysfunction. Neither analysis tested whether that translates into fewer symptoms or a specific health outcome, and the underlying trials varied widely in quality and design.
What dose of zinc reduces CRP?
The 2021 meta-analysis of 8 trials found a larger CRP difference at doses of 50 mg/day or more than at lower doses — above the 40 mg/day adult upper intake level for ongoing use. That's a research finding about a blood marker, not a dosing recommendation.
Does zinc help with chronic pain or arthritis?
Neither meta-analysis reviewed here tested arthritis, chronic pain, or any other named inflammatory disease as an outcome — both measured blood markers only. There's no trial cited on this page for a specific inflammatory condition.
When to talk to a doctor
A chronic inflammatory condition, unexplained fatigue, or persistent joint pain should be evaluated by a doctor, who can test relevant markers and discuss treatment directly. Zinc is not a treatment for any diagnosed inflammatory or autoimmune condition, and nothing in the evidence above supports using it as a substitute for medical care. If you take medication or are pregnant or nursing, talk to a doctor before adding any supplement.
Related reading: zinc benefits: what the research does and doesn't show, how much zinc should you take a day, and who should not take zinc.
Sources
- The effect of zinc supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials A 2021 meta-analysis of 8 randomized trials found zinc supplementation lowered CRP by about 1.68 mg/L on average, with a larger effect at 50 mg/day or more and in people with kidney dysfunction, and a larger apparent effect in lower-quality studies.
- Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials A 2021 meta-analysis of 21 randomized trials (1,321 adults) found zinc supplementation associated with lower CRP, TNF-alpha and a marker of oxidative stress, though the studies varied widely in design and results (very high heterogeneity for most markers).
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.